Health Care & Life Sciences » Pharmaceuticals | Stallergenes Greer PLC

Stallergenes Greer PLC | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
248,148.00
251,281.00
81,822.00
186,388.00
260,231.00
Cost of Goods Sold (COGS) incl. D&A
52,008.00
58,244.00
37,966.00
85,331.00
94,458.00
Gross Income
196,140.00
193,037.00
43,856.00
101,057.00
165,773.00
SG&A Expense
145,382.00
145,762.00
109,809.00
200,979.00
176,578.00
EBIT
45,811.00
43,292.00
65,953.00
98,890.00
10,805.00
Unusual Expense
4,337.00
4,553.00
9,211.00
3,506.00
-
Non Operating Income/Expense
9,281.00
11,191.00
805.00
-
958.00
Interest Expense
1,378.00
20.00
359.00
699.00
1,817.00
Pretax Income
52,498.00
51,824.00
76,249.00
102,486.00
13,560.00
Income Tax
12,133.00
8,474.00
26,995.00
42,120.00
4,267.00
Equity in Affiliates
-
30.00
27.00
156.00
578.00
Consolidated Net Income
40,365.00
43,320.00
49,281.00
60,522.00
9,871.00
Net Income
40,365.00
43,320.00
49,281.00
60,522.00
9,871.00
Net Income After Extraordinaries
40,365.00
43,320.00
49,281.00
60,522.00
9,871.00
Net Income Available to Common
40,365.00
43,320.00
49,281.00
60,522.00
9,871.00
EPS (Basic)
2.96
3.13
6.12
3.07
0.50
Basic Shares Outstanding
13,654.10
13,822.80
8,058.00
19,711.50
19,738.70
EPS (Diluted)
2.94
3.12
6.12
3.07
0.50
Diluted Shares Outstanding
13,718.00
13,904.60
8,058.00
19,711.50
19,738.70
EBITDA
58,380.00
56,086.00
53,061.00
73,643.00
12,141.00
Other Operating Expense
4,947.00
3,983.00
-
1,032.00
-
Non-Operating Interest Income
3,121.00
1,914.00
79.00
609.00
20.00

About Stallergenes Greer

View Profile
Address
40 Bernard Street
London Greater London WC1N 1LE
United Kingdom
Employees -
Website http://stallergenes.co.uk
Updated 09/14/2018
Stallergenes Greer Plc is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. It operates through the following geigraphical segments: Southern Europe; Northern and Central Europe; Internation Markets; and United States.